RITTER PHARMACEUTICALS INC — Form D

RITTER PHARMACEUTICALS INC of LOS ANGELES, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-09. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (47)

Showing 25 of 47 people.

NameRoleLocation
Noah E DoyleDirectorLos Angeles, CA
Matthew W FoehrDirectorEmeryville, CA
Paul V MaierDirectorDeer Park, IL
William M MerinoDirectorLos Angeles, CA
Andrew J RitterDirectorLos Angeles, CA
Ira E RitterDirectorNew York, NY
Michael D StepDirectorLos Angeles, CA
John W BeckExecutive OfficerLa Jolla, CA
Andrew J RitterExecutive OfficerLos Angeles, CA
Ira E RitterExecutive OfficerNew York, NY
Braeden LichtiDirectorHARVARD, MA
Graydon BenslerDirectorHARVARD, MA
Robert B LimDirectorCarlsbad, CA
Kevin Richardson IIDirectorCarlsbad, CA
Kevin Richardson IIExecutive OfficerCarlsbad, CA
Campbell BecherDirectorCarlsbad, CA
Campbell BecherExecutive OfficerCarlsbad, CA
Cody B PriceDirectorCarlsbad, CA
Andrew RitterDirectorSAN FRANCISCO, CA
Andrew RitterExecutive OfficerSAN FRANCISCO, CA
Robert LimDirectorCarlsbad,, CA
Cody PriceDirectorCarlsbad,, CA
Noah DoyleDirectorSan Francisco, CA
Thomas J AdamekDirectorBaton Rouge, LA
Ira RitterDirectorIrvine, CA

Other filings by this issuer (10)

FiledFormOfferingSold
2025-08-13D$4.5M$4.5M
2024-11-22D$5.1M$5.1M
2014-12-16D$5.7M$3.7M
2013-11-22D/A$7.4M$7.4M
2012-08-07D/A$6.8M$5.8M
2012-02-23D$3.5M$526K
2010-11-30D$5.0M$2.0M
2010-10-12D$250K$250K
2010-03-19D$453K$453K
2009-08-17D$1.0M$1.0M

More